Pain affects up to 1.9 Billion people globally, with massive associated healthcare costs. However, measuring pain has always been a challenge in the medical field. Many tests are too one-dimensional and only measure pain at one point of time, mostly determined by the physician. Mundipharma – a global network of independent associated companies focusing on the development of medicines that meet real-world patients’ needs – has the solution: Painfocus.
Painfocus is a revolutionary new end-to-end pain management solution that significantly increases the objectivity of pain measurement, something that has been historically difficult. According to the company, the solution has the potential to completely-transform how caregivers and doctors manage their patients’ pain.
“The ability to objectively assign a value to pain has the potential to transform how clinicians assess and manage their patients, resulting in a more optimal care pathway,” said Raman Singh, CEO of Mundipharma.
Painfocus uses advanced machine learning that combines multiple physiology biomarkers captured using wearable devices to calculate the presence and severity of pain. One of the underlying technologies is Everion, developed by the Swiss startup Biovotion. Everion is a wearable device worn on the upper-arm, comprising of an unrivalled number of precise sensors that facilitate continuous real-time data collection.
With painfocus, Everion is used as standard data input in combination with Biofourmis’ AI-empowered health analytics platform, Biovitals, which uses advanced machine learning, combining multiple physiology biomarkers to calculate the presence and severity of pain.
The painfocus app is used to capture, monitor and analyse data generated by patients in an inpatient or outpatient setting. The data is shared with caregivers to give them an accurate picture of the patient’s health including level of pain, quality of life and general physiology in real-time via a web-based dashboard. It also enables digital patient-caregiver communication, which is particularly significant for patients who do not have the ability to verbally explain how they are suffering.
Accroding to the startup: “This is just one example of the impact Everion has on digitally transforming health and healthcare. Wherever high user adoption allowing long-term use, accuracy and reliability is needed, Everion becomes the device of choice providing 22 parameters and features continuously and in medical grade quality.”